The impact of radiogenomics on breast cancer

Advances in radiomics and machine learning techniques have facilitated the extraction of quantitative radiomic features that can be correlated with genomic data. Breast MRI-based radiogenomics, which combines MRI radiomics and genomics, is an emerging field that non-invasively reflects tumor heterogeneity and assesses the biological behaviour of breast cancer. Studies have shown that radiogenomics has the potential to replace traditional genetic testing for breast cancer, reducing the need for invasive procedures such as biopsies. In the future, the clinical application of radiogenomics as a tool for molecular subtype identification, treatment response and prognosis prediction, and recurrence risk assessment is both necessary and feasible.